-
Lambda Protein Phosphatase for BMAL1 Studies
2026-08-23
Use λ-PPase to distinguish phosphorylation-dependent biology from antibody or sample artifacts, with a practical workflow for BMAL1 condensate research. The RNase-free, dual-specificity enzyme also supports antibody validation, phosphorylation site validation, and controlled protein dephosphorylation assays.
-
GTP Solution (100 mM) for mRNA Workflows
2026-08-22
GTP Solution (100 mM) is a nuclease-free, high-purity Guanosine-5'-triphosphate stock for enzyme-dependent RNA synthesis and nucleotide assays. Its defined concentration, near-neutral pH, and controlled storage guidance support reproducible upstream workflows, including research connected to p21 mRNA–LNP delivery.
-
Minocycline HCl in Retinal Microglia Assays
2026-08-21
Minocycline HCl provides a practical pharmacologic control for testing whether 40-Hz flicker improves amyloid-β clearance through microglial activity. This workflow connects MHC-II imaging and biochemical endpoints with ERG and OKR measurements while highlighting formulation, specificity, and interpretation safeguards.
-
CLCC1 Promotes Herpesvirus Nuclear Egress Fusion
2026-08-21
A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion stage of herpesvirus nuclear egress. Genetic loss of CLCC1 causes perinuclear capsid accumulation, impaired viral release, and defects in nuclear pore complex insertion, linking viral trafficking with nuclear-envelope morphogenesis.
-
Methylprednisolone Workflows for Bone Loss Research
2026-08-20
Build reproducible Methylprednisolone studies by connecting glucocorticoid-driven inflammatory signaling with osteoclast and tissue-level endpoints. This workflow combines practical stock preparation, in vitro anti-inflammatory assays, and the reference study’s micro-CT, angiography, histology, and molecular framework.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-20
EZ Cap Cy5 Firefly Luciferase mRNA links direct Cy5-based transport measurements with Firefly luciferase expression analysis. This guide explains how to interpret the two signals, design defensible mRNA delivery and transfection experiments, and apply evidence from a recent lipoplex study.
-
Antipyrine in BBB Permeability Workflows
2026-08-19
Antipyrine offers a highly soluble, high-purity research compound for building reproducible permeability, transport, and pharmacokinetic workflows. Used alongside LLC-PK1-MOCK/MDR1 assays, it helps separate practical assay variability from transporter effects and lysosomal trapping while supporting pain, fever, and CNS research applications.
-
BMS 309403 Workflow for FABP4 Research
2026-08-19
Build reproducible macrophage, foam-cell, vascular, and metabolic assays around BMS 309403, a potent and selective FABP4 inhibitor. This guide connects compound handling and dose design with the SERCA2–calcineurin–FoxO1–FABP4 mechanism implicated in atherosclerosis and inflammation.
-
High-Throughput Surrogate Models for BBB Permeability
2026-08-18
Hu and colleagues developed a Transwell blood-brain barrier surrogate using LLC-PK1-MOCK/MDR1 cells and combined permeability, P-glycoprotein efflux, and recovery measurements with lysosomal-trapping correction. Across 41 compounds, the approach correlated in vitro transport with unbound brain distribution and offered a practical framework for earlier CNS candidate prioritization.
-
Proteome Preservation in Bone Regeneration Research
2026-08-18
A translational perspective on how MS-compatible protease control can preserve mechanistic evidence in irradiated BMSC and migrasome research, with practical guidance for using APExBIO Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO).
-
GDC-0068 (RG7440) for Spatial mTORC1 Assays
2026-08-17
GDC-0068 (RG7440) provides a selective pan-AKT perturbation strategy for linking PI3K/Akt signaling to cell fate, genotype-dependent drug response, and mTORC1 output. Used alongside compartment-targeted tools, it helps distinguish upstream pathway dependence from the spatial functions of nuclear and lysosomal mTORC1.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-08-17
Use α-Bungarotoxin to convert α7 nAChR activation from an assumption into a testable experimental variable across neuronal, neuromuscular, and placental models. This guide combines receptor-blockade workflows, pathway-level controls, assay optimization, and troubleshooting for cholinergic signaling studies.
-
3X FLAG Peptide for Translational Mechanism
2026-08-16
Mechanistic studies of CDK4, 4E-BP1, and mTOR inhibitor resistance require more than a phosphorylation signal: they require confident protein recovery, identity confirmation, and functional follow-through. This thought-leadership guide explains how the 3X (DYKDDDDK) Peptide can strengthen FLAG-based assay architecture while preserving a disciplined connection between chemoproteomic discovery and translational validation.
-
Chlorin e6: PDT Workflows and Optimization
2026-08-15
Chlorin e6 supports controllable ROS-based experiments spanning cancer-cell photodynamic therapy and antibacterial wound-material research. This workflow-focused guide connects free Ce6 dosing, light calibration, apoptosis assays, and Ce6-functionalized silk fibroin scaffolds while emphasizing controls and troubleshooting.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-14
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may be poorly separated by conventional Tris-SDS-PAGE. It supports research workflows including denaturing and non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.